Health
Preventative nasal spray shown to reduce viral replication by up to 96% in COVID-19 challenge study – PharmiWeb.com
New preventative nasal spray treatment that could protect people from COVID-19 infection and prevent transmission announced Novel therapy developed by Australian biotech company, Ena Respiratory, shown to significantly reduce COVID-19 virus levels in the nose…
- New preventative nasal spray treatment that could protect people from COVID-19 infection and prevent transmission announced
- Novel therapy developed by Australian biotech company, Ena Respiratory, shown to significantly reduce COVID-19 virus levels in the nose and throat, in a gold-standard animal study
- Reduced COVID-19 replication by up to 96%, study performed by Public Health England (PHE) scientists
- Mode of action complementary to COVID-19 vaccines, with easy n…
Continue Reading
-
General21 hours agoIsraeli forces open fire towards diplomatic delegation touring Jenin in the northern West Bank
-
General18 hours agoRegional house price growth outstrips capital cities
-
General18 hours agoRestaurants on the brink as business failures plateau
-
General15 hours agoCharlotte McConaghy calls for climate change action in new novel Wild Dark Shore